REPORT ID 3405

EMEA (Europe, Middle East and Africa) Lysosomal Alpha Glucosidase Market Report 2017

Publish Date
13-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the EMEA Lysosomal Alpha Glucosidase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Lysosomal Alpha Glucosidase for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Lysosomal Alpha Glucosidase market competition by top manufacturers/players, with Lysosomal Alpha Glucosidase sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amicus Therapeutics Inc
    Audentes Therapeutics Inc
    Etubics Corp
    Genzyme Corp
    greenovation Biotech GmbH
    Huons Co Ltd
    JCR Pharmaceuticals Co Ltd
    Oxyrane Belgium NV
    Pharming Group NV
    Sarepta Therapeutics Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    AT-982
    ATB-200
    AVRRD-03
    JR-162
    MOSS-GAA
    OXY-2810
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Glycogen Storage Disease
    Pompe Disease
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Lysosomal Alpha Glucosidase Market Report 2017
1 Lysosomal Alpha Glucosidase Overview
    1.1 Product Overview and Scope of Lysosomal Alpha Glucosidase
    1.2 Classification of Lysosomal Alpha Glucosidase
        1.2.1 EMEA Lysosomal Alpha Glucosidase Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Lysosomal Alpha Glucosidase Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 AT-982
        1.2.4 ATB-200
        1.2.5 AVRRD-03
        1.2.6 JR-162
        1.2.7 MOSS-GAA
        1.2.8 OXY-2810
        1.2.9 Others
    1.3 EMEA Lysosomal Alpha Glucosidase Market by Application/End Users
        1.3.1 EMEA Lysosomal Alpha Glucosidase Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Glycogen Storage Disease
        1.3.3 Pompe Disease
        1.3.4 Others
    1.4 EMEA Lysosomal Alpha Glucosidase Market by Region
        1.4.1 EMEA Lysosomal Alpha Glucosidase Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Lysosomal Alpha Glucosidase (2012-2022)
        1.5.1 EMEA Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Lysosomal Alpha Glucosidase Revenue and Growth Rate (2012-2022)

2 EMEA Lysosomal Alpha Glucosidase Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Lysosomal Alpha Glucosidase Market Competition by Players/Manufacturers
        2.1.1 EMEA Lysosomal Alpha Glucosidase Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Lysosomal Alpha Glucosidase Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Lysosomal Alpha Glucosidase Sale Price by Players (2012-2017)
    2.2 EMEA Lysosomal Alpha Glucosidase (Volume and Value) by Type/Product Category
        2.2.1 EMEA Lysosomal Alpha Glucosidase Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Lysosomal Alpha Glucosidase Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Lysosomal Alpha Glucosidase Sale Price by Type (2012-2017)
    2.3 EMEA Lysosomal Alpha Glucosidase (Volume) by Application
    2.4 EMEA Lysosomal Alpha Glucosidase (Volume and Value) by Region
        2.4.1 EMEA Lysosomal Alpha Glucosidase Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Lysosomal Alpha Glucosidase Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Lysosomal Alpha Glucosidase Sales Price by Region (2012-2017)

3 Europe Lysosomal Alpha Glucosidase (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Lysosomal Alpha Glucosidase Sales and Value (2012-2017)
        3.1.1 Europe Lysosomal Alpha Glucosidase Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Lysosomal Alpha Glucosidase Revenue and Growth Rate (2012-2017)
    3.2 Europe Lysosomal Alpha Glucosidase Sales and Market Share by Type
    3.3 Europe Lysosomal Alpha Glucosidase Sales and Market Share by Application
    3.4 Europe Lysosomal Alpha Glucosidase Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Lysosomal Alpha Glucosidase Sales Volume by Countries (2012-2017)
        3.4.2 Europe Lysosomal Alpha Glucosidase Revenue by Countries (2012-2017)
        3.4.3 Germany Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        3.4.4 France Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        3.4.5 UK Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        3.4.6 Russia Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        3.4.7 Italy Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)

4 Middle East Lysosomal Alpha Glucosidase (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Lysosomal Alpha Glucosidase Sales and Value (2012-2017)
        4.1.1 Middle East Lysosomal Alpha Glucosidase Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Lysosomal Alpha Glucosidase Revenue and Growth Rate (2012-2017)
    4.2 Middle East Lysosomal Alpha Glucosidase Sales and Market Share by Type
    4.3 Middle East Lysosomal Alpha Glucosidase Sales and Market Share by Application
    4.4 Middle East Lysosomal Alpha Glucosidase Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Lysosomal Alpha Glucosidase Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Lysosomal Alpha Glucosidase Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        4.4.4 Israel Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        4.4.5 UAE Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        4.4.6 Iran Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)

5 Africa Lysosomal Alpha Glucosidase (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Lysosomal Alpha Glucosidase Sales and Value (2012-2017)
        5.1.1 Africa Lysosomal Alpha Glucosidase Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Lysosomal Alpha Glucosidase Revenue and Growth Rate (2012-2017)
    5.2 Africa Lysosomal Alpha Glucosidase Sales and Market Share by Type
    5.3 Africa Lysosomal Alpha Glucosidase Sales and Market Share by Application
    5.4 Africa Lysosomal Alpha Glucosidase Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Lysosomal Alpha Glucosidase Sales Volume by Countries (2012-2017)
        5.4.2 Africa Lysosomal Alpha Glucosidase Revenue by Countries (2012-2017)
        5.4.3 South Africa Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Lysosomal Alpha Glucosidase Sales and Growth Rate (2012-2017)

6 EMEA Lysosomal Alpha Glucosidase Manufacturers/Players Profiles and Sales Data
    6.1 Amicus Therapeutics Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Amicus Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Audentes Therapeutics Inc
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Audentes Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Etubics Corp
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Etubics Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Genzyme Corp
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Genzyme Corp Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 greenovation Biotech GmbH
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 greenovation Biotech GmbH Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Huons Co Ltd
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Huons Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 JCR Pharmaceuticals Co Ltd
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 JCR Pharmaceuticals Co Ltd Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Oxyrane Belgium NV
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Oxyrane Belgium NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Pharming Group NV
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Pharming Group NV Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Sarepta Therapeutics Inc
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Lysosomal Alpha Glucosidase Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Sarepta Therapeutics Inc Lysosomal Alpha Glucosidase Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Lysosomal Alpha Glucosidase Manufacturing Cost Analysis
    7.1 Lysosomal Alpha Glucosidase Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Lysosomal Alpha Glucosidase

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Lysosomal Alpha Glucosidase Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Lysosomal Alpha Glucosidase Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Lysosomal Alpha Glucosidase Market Forecast (2017-2022)
    11.1 EMEA Lysosomal Alpha Glucosidase Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Lysosomal Alpha Glucosidase Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Lysosomal Alpha Glucosidase Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Lysosomal Alpha Glucosidase Price and Trend Forecast (2017-2022)
    11.2 EMEA Lysosomal Alpha Glucosidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Lysosomal Alpha Glucosidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Lysosomal Alpha Glucosidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Lysosomal Alpha Glucosidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Lysosomal Alpha Glucosidase Sales Forecast by Type (2017-2022)
    11.7 EMEA Lysosomal Alpha Glucosidase Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer